Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB)

CUSIP: 45782T105

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
27,969,231
Total 13F shares
793,136
Share change
-128,384
Total reported value
$13,655,776
Price per share
$17.21
Number of holders
25
Value change
+$1,189,170
Number of buys
16
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 45782T105?
CUSIP 45782T105 identifies INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Granite Point Capital Management, L.P.
13F
Company
0.89%
250,000
$2,578,000 30 Sep 2020
13F
VANGUARD GROUP INC
13F
Company
0.74%
206,695
$2,131,000 30 Sep 2020
13F
Point72 Asset Management, L.P.
13F
Company
0.36%
100,000
$1,031,000 30 Sep 2020
13F
DEUTSCHE BANK AG\
13F
Company
0.34%
96,048
$990,000 30 Sep 2020
13F
Informed Momentum Co LLC
13F
Company
0.26%
73,734
$760,000 30 Sep 2020
13F
BANK OF MONTREAL /CAN/
13F
Company
0.22%
61,221
$651,000 30 Sep 2020
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.14%
40,000
$412,000 30 Sep 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.11%
30,023
$309,000 30 Sep 2020
13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC
13F
Company
0.09%
26,300
$271,000 30 Sep 2020
13F
Qube Research & Technologies Ltd
13F
Company
0.09%
23,981
$247,000 30 Sep 2020
13F
BlackRock Finance, Inc.
13F
Company
0.07%
18,389
$190,000 30 Sep 2020
13F
Financial Advocates Investment Management
13F
Company
0.06%
18,167
$187,000 30 Sep 2020
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.06%
16,028
$165,000 30 Sep 2020
13F
Fortis Group Advisors, LLC
13F
Company
0.04%
10,000
$103,000 30 Sep 2020
13F
OSAIC HOLDINGS, INC.
13F
Company
0.02%
6,000
$62,000 30 Sep 2020
13F
FNY Investment Advisers, LLC
13F
Company
0.01%
3,600
$37,000 30 Sep 2020
13F
BARCLAYS PLC
13F
Company
0.01%
2,813
$29,000 30 Sep 2020
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.01%
2,700
$28,000 30 Sep 2020
13F
Advisory Services Network, LLC
13F
Company
0%
1,363
$14,000 30 Sep 2020
13F
Covington Capital Management
13F
Company
0%
1,000
$10,000 30 Sep 2020
13F
Cubist Systematic Strategies, LLC
13F
Company
0%
1,000
$10,000 30 Sep 2020
13F
MORGAN STANLEY
13F
Company
0%
1,000
$10,000 30 Sep 2020
13F
TRUE Private Wealth Advisors
13F
Company
0%
1,000
$10,000 30 Sep 2020
13F
Federation Des Caisses Desjardins du Quebec
13F
Individual
0%
800
$8,248 30 Sep 2020
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
600
$6,000 30 Sep 2020
13F
Prospera Financial Services Inc
13F
Company
0%
175
$2,000 30 Sep 2020
13F
ROYAL BANK OF CANADA
13F
Company
0%
104
$1,000 30 Sep 2020
13F

Institutional Holders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) as of Q4 2020

As of 31 Dec 2020, Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 793,136 shares. The largest 10 holders included VANGUARD GROUP INC, Ikarian Capital, LLC, DEUTSCHE BANK AG\, ROYAL BANK OF CANADA, GEODE CAPITAL MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, BlackRock Inc., Financial Advocates Investment Management, SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, and Diametric Capital, LP. This page lists 25 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders
27
Q4 2020 holders
25
Holder diff
-2
Investor Q3 2020 Shares Q4 2020 Shares Share Diff Share Chg % Q3 2020 Value $ Q4 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .